Omnicell (NASDAQ:OMCL) Issues Q2 Earnings Guidance

Omnicell (NASDAQ:OMCL) issued an update on its second quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.10-0.20 for the period, compared to the consensus estimate of $0.27. The company issued revenue guidance of $250-260 million, compared to the consensus revenue estimate of $261.84 million. Omnicell also updated its FY24 guidance to $0.90-1.40 EPS.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on OMCL. Wells Fargo & Company lowered their target price on shares of Omnicell from $28.00 to $26.00 and set an equal weight rating on the stock in a report on Friday, February 9th. Benchmark reiterated a buy rating and set a $38.00 price objective on shares of Omnicell in a research note on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Hold and an average price target of $42.20.

Omnicell Stock Up 2.9 %

NASDAQ:OMCL opened at $30.13 on Friday. The company has a quick ratio of 2.22, a current ratio of 2.38 and a debt-to-equity ratio of 0.48. Omnicell has a twelve month low of $25.69 and a twelve month high of $77.14. The stock’s 50-day simple moving average is $27.73 and its 200 day simple moving average is $31.72.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of ($0.10) by $0.22. The business had revenue of $258.85 million during the quarter, compared to the consensus estimate of $256.00 million. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. Equities analysts predict that Omnicell will post 0.09 earnings per share for the current fiscal year.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.